Krystal Biotech (KRYS) Other Gross PP&E Adjustments (2021 - 2025)
Historic Other Gross PP&E Adjustments for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $163.4 million.
- Krystal Biotech's Other Gross PP&E Adjustments rose 103.2% to $163.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $163.4 million, marking a year-over-year increase of 103.2%. This contributed to the annual value of $163.4 million for FY2025, which is 103.2% up from last year.
- Krystal Biotech's Other Gross PP&E Adjustments amounted to $163.4 million in Q4 2025, which was up 103.2% from $164.2 million recorded in Q3 2025.
- Krystal Biotech's 5-year Other Gross PP&E Adjustments high stood at $167.7 million for Q3 2024, and its period low was $32.4 million during Q1 2021.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was $160.6 million (2023), whereas its average is $139.6 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first surged by 29822.78% in 2022, then crashed by 206.9% in 2025.
- Krystal Biotech's Other Gross PP&E Adjustments (Quarter) stood at $105.4 million in 2021, then soared by 45.1% to $153.0 million in 2022, then rose by 4.31% to $159.6 million in 2023, then rose by 1.34% to $161.7 million in 2024, then increased by 1.03% to $163.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at $163.4 million for Q4 2025, versus $164.2 million for Q3 2025 and $164.1 million for Q2 2025.